Cytomegalovirus in urinary sediment in patients with acute kidney injury

Sahra Pajenda1, Sebastian Kapps2, Daniela Gerges2

  • 1Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. sahra.pajenda@meduniwien.ac.at.

BMC Nephrology
|May 8, 2021
PubMed
Abstract

Insights

Human cytomegalovirus (HCMV) RNA transcripts were detected in the urine sediment of immunosuppressed patients with acute kidney injury. This novel urinalysis method may aid in noninvasively detecting HCMV infections in renal transplant recipients.

Area of Science:

  • Nephrology
  • Virology
  • Transplantation Immunology

Background:

  • Solid organ transplantation requires immunosuppression, increasing infection risk.
  • Renal allograft recipients are prone to opportunistic infections like human cytomegalovirus (HCMV).
  • Current methods like immunohistology may miss localized HCMV infections in kidney allografts.

Purpose of the Study:

  • To investigate the presence of HCMV-specific RNA transcripts in urine sediment of patients with acute kidney injury (AKI).
  • To evaluate urinalysis as a noninvasive method for HCMV detection in renal transplant recipients (RTX) and non-transplant recipients (nRTX).

Main Methods:

  • Collected morning urine sediment from 90 patients with AKI (48 RTX, 42 nRTX).
  • Performed RNA extraction and reverse transcription.
  • Quantified HCMV transcripts using real-time quantitative polymerase chain reaction (RT-qPCR) with a UL132-specific probe.

Main Results:

  • HCMV transcripts were found in urine sediment of 10 out of 48 RTX patients.
  • Three RTX patients with detectable HCMV transcripts had negative serology but received organs from seropositive donors.
  • All three RTX patients on belatacept-based immunosuppression showed HCMV transcripts; two nRTX patients also tested positive.

Conclusions:

  • HCMV positivity in urine sediment is associated with immunosuppression in patients with AKI.
  • Urinalysis for HCMV RNA transcripts offers a novel, noninvasive detection method.
  • Further research is needed to determine if this method detects all HCMV infections or only those with active viral replication.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
114
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
100
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
171
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
231
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
379
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
466